Microbiome Sequencing Services Market in terms of revenue was estimated to be worth $284 million in 2022 and is poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2022 to 2028 according to a new report by MarketsandMarkets™.

1. Resources Blog Journalists Log In Sign Up Data Privacy Send a Release
Search
News Products Contact 
News in Focus Business & Money Science & Tech Lifestyle & Health Policy & Public Interest People & Culture
Microbiome Sequencing
Services Market worth $555
million | MarketsandMarkets
NEWS PROVIDED BY
MarketsandMarkets
17 May, 2023, 13:00 ET

SHARE THIS ARTICLE
     
CHICAGO, May 17, 2023 /PRNewswire/ -- The microbiome sequencing services industry is poised for significant growth in
the near future. The microbiome, comprising the diverse community of microorganisms living in and on the human body,
has been increasingly recognized for its impact on human health and disease. As research in this field expands, there is a
growing demand for microbiome sequencing services to analyze and understand the composition, function, and
interactions of these microbial communities. Advances in next-generation sequencing technologies have enabled more
comprehensive and cost-effective analysis of the microbiome, leading to increased adoption of microbiome sequencing
services by academic institutions, pharmaceutical companies, and healthcare providers. The industry is witnessing a surge
in collaborations and partnerships between sequencing service providers and research organizations to facilitate large-
scale microbiome studies. Additionally, the integration of bioinformatics tools and artificial intelligence algorithms is
enhancing data analysis and interpretation, enabling researchers to uncover novel insights into the role of the
microbiome in various diseases. Overall, the microbiome sequencing services industry is expected to play a pivotal role in
advancing our understanding of the human microbiome and its implications for personalized medicine, disease
diagnosis, and therapeutic development in the near future.
Microbiome Sequencing Services Market in terms of revenue was estimated to be worth $284 million in 2022 and is
poised to reach $555 million by 2028, growing at a CAGR of 14.3% from 2022 to 2028 according to a new report by
MarketsandMarkets™. Key driving factors of the microbiome sequencing services market growth include, expanding
applications for metagenomic sequencing, high focus on development of human microbiome therapeutics, and high
costs associated with sophisticated sequencing instruments. In recent years, there has been a significant increase in the
demand for metagenomic sequencing in the field of microbiome research owing it its wide array of applications, such as
disease diagnosis, drug discovery, and precision medicine. This is expected to boost the market growth.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94324380
Browse in-depth TOC on "Microbiome Sequencing Services Market"
186 - Tables
35 - Figures
200 - Pages
Microbiome Sequencing Services Market Scope:
Report Coverage Details
Market Revenue in 2022 $284 million
Estimated Value by 2028 $555 million
Growth Rate Poised to grow at a CAGR of 14.3%
Market Size Available for 2021–2028
Forecast Period 2023–2028
Forecast Units Value (USD Million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Service, Type, Technology, End User, And Region
Geographies Covered North America, Europe, Asia Pacific, Latin America and MEA
Report Highlights Updated financial information / product portfolio of players
Key Market Opportunities Expanding applications of microbiome sequencing in therapeutics development

2. Key Market Drivers High cost of advanced infrastructure for sequencing
The sequencing and library preparation services segment accounted for the largest share of the microbiome
sequencing services market in 2022
Based on service, the microbiome sequencing services market is segmented into sample preparation services, sequencing
and library preparation services, and data analysis services. Sequencing and library preparation services are expected to
dominate market through the forecast period. This segment includes sequencing and library preparation services for
samples subjected to microbiome sequencing. This is a crucial step in microbiome analysis, wherein either reference
sequences are created for samples or sequencing outputs are compared against the existing sequences.
The shotgun sequencing segment is expected to grow at the highest CAGR from 2023 to 2028
Based on type, the global microbiome sequencing services market is segmented into amplicon sequencing, whole-
genome sequencing, shotgun sequencing, and other types. Advancements in data analysis solutions is expected to drive
the adoption of shotgun sequencing, rendering this segment with a highest growth rate. Shotgun sequencing is a
relatively new approach used to analyze many organisms present in a given complex sample and comprehensively
sequence all genes.
The academic and research institutes segment accounted for the largest share of the global microbiome
sequencing services market in 2022
Based on end user, the global microbiome sequencing services market is segmented into pharmaceutical and
biotechnology companies, academic and research institutes, and other end users. Expanding applications of microbiome
research is expected to drive the growth of academic and research institutes end user segment. This segment is inclusive
of the application of microbiome sequencing services in environmental and ecological research, veterinary research, and
other research activities conducted by academic and research institutes.
North America dominates the global microbiome sequencing services market throughout the forecast period
The microbiome sequencing services market is segmented into five major regional segments, namely, North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America accounted for the largest share in the
microbiome sequencing services market, which is attributed to the established research infrastructure, technological
advancements, and demand for precision medicine. There has been a growing recognition of the role of the microbiome
in various conditions, including gastrointestinal disorders, metabolic diseases, neurodegenerative diseases, and immune-
related disorders. This increased awareness has led to a rising demand for microbiome sequencing services to better
understand the complex interactions between the human microbiome and host health, as well as to develop targeted
interventions and therapies in turn contributing to the regional revenue growth.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=94324380
Microbiome Sequencing Services Market Dynamics:
Drivers:
1. Increased Focus on Human Microbiome Therapy
2. Human Microbiome as New Validated Target for Drug Development
3. Human Microbiome for Early Disease Detection and Diagnosis
Restraints:
1. Lack of Expertise and Detailed Research
2. Barriers in Proving the Causal Link Between Dysbiosis and Disease
Opportunities:
1. Investigational New Drug (IND) Requirements for Fecal Microbiota
2. Increasing Collaborations Create Growth Opportunities
Challenges:

3. 1. Government Regulations
Burning Issues
1. Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
2. Development of Human Microbiome Therapeutic Products
Key Market Players:
The microbiome sequencing services market is fragmented in nature with a large pool of local service providers/emerging
players operating in this market. Some of the prominent market players include Charles River Laboratories (US), Eurofins
Scientific (France), BGI (China), CosmosID (US), Microba (Australia), QIAGEN (Germany), Microbiome Insights (Canada),
BaseClear (Netherlands), CD Genomics (US), Zymo Research (US), OraSure Technologies (US), MR DNA (US), Eremid
Genomic Services (US), Clinical-Microbiomics A/S (Denmark), Novogene Co., Ltd. (China), EzBiome (US), Boster Biological
Technology (US), Zifo (India), omics2view.consulting GbR (Germany), and Macrogen, Inc. (South Korea).
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94324380
Recent Developments:
In March 2023, Microba launched a new human gut microbiome testing service for comprehensive gastrointestinal
testing solutions. The solutions are accessible to healthcare professionals in Australia through a different brand
name, Co-Biome.
In February 2023, Locus Biosciences announced a long-term partnership with CosmosID to gain the support of the
latter for clinical trial studies. CosmosID's support for microbiome analysis is expected to assist Locus Biosciences in
strengthening its precision therapeutics platform.
In March 2022, Diversigen announced the launch of a new service, metatranscriptomic sequencing and analysis of
the gut microbiome. This service will assist research professionals in understanding gene expression while gaining
insights into both function and mechanism of microbiomes in samples.
Microbiome Sequencing Services Market Advantages:
Comprehensive Analysis: Microbiome sequencing services offer comprehensive analysis of the microbial
communities present in various sample types, providing detailed insights into their composition, diversity, and
function. This allows researchers to understand the role of the microbiome in health and disease.
High-throughput and Cost-effective: Next-generation sequencing technologies have significantly increased the
throughput of microbiome sequencing, allowing for the analysis of large sample sizes in a shorter time frame. This
scalability, coupled with cost-effective sequencing platforms, enables researchers to generate extensive microbiome
data at a reasonable cost.
Customized Solutions: Microbiome sequencing service providers offer tailored solutions to meet the specific needs of
researchers. They provide a range of sequencing platforms, library preparation protocols, and bioinformatics analysis
tools, allowing researchers to design experiments and obtain insights that align with their research objectives.
Expertise and Infrastructure: Microbiome sequencing service providers possess specialized expertise and
infrastructure dedicated to handling and processing microbiome samples. They have streamlined protocols and
quality control measures in place to ensure accurate and reproducible results.
Data Interpretation and Analysis: Microbiome sequencing services often include comprehensive bioinformatics
analysis, utilizing advanced algorithms and databases to interpret and extract meaningful information from the
generated data. This allows researchers to gain valuable insights into the microbiome composition, functional
potential, and interactions with the host.
Collaboration Opportunities: Microbiome sequencing services foster collaborations between researchers, clinicians,
and industry stakeholders. By outsourcing the sequencing and analysis tasks to specialized service providers,
researchers can focus on their core expertise while leveraging the expertise and resources of the service providers.
Translational Applications: The insights gained from microbiome sequencing services have broad translational
applications in various fields, including personalized medicine, drug discovery and development, agriculture, and
environmental studies. By understanding the role of the microbiome in different contexts, researchers can develop
targeted interventions and therapies for various diseases and conditions.
Overall, microbiome sequencing services provide researchers with a valuable tool to explore the complex microbial
communities and their interactions with the host, offering a wide range of advantages for advancing our understanding of

4. the microbiome and its impact on human health.
Related Reports:
Human Microbiome Market - Global Forecasts to 2029
Lab Automation Market - Global Forecasts to 2028
Liquid Handling System Market - Global Forecasts to 2027
Clinical Microbiology Market - Global Forecasts to 2025
High Throughput Screening Market - Global Forecasts to 2025
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-
machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on
emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing
revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion
opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain,
Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay
relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-
powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud)
integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the
entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/microbiome-sequencing-service-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/microbiome-sequencing-service.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
Also from this source
Smart Locker Market worth $3.6 billion by 2028 -
Exclusive Report by MarketsandMarkets™
The Smart Locker Market is projected to grow from USD 2.1 billion
in 2023 and is estimated to reach USD 3.6 billion by 2028; it is
expected to grow...
Explore
Health Care &
Hospitals
Medical
Pharmaceuticals

5. Anti-aircraft warfare market worth $28.6 billion by
2028 - Exclusive Report by MarketsandMarkets™
The Anti-aircraft warfare market is projected to grow from USD
20.9 billion in 2023 and is estimated to reach USD 28.6 billion by
2028; it is...
More Releases From This Source
News Releases in Similar Topics
Biotechnology Pharmaceuticals
Sign up to get PRN’s top stories and curated news
delivered to your inbox weekly!
Submit
By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each
subscriber's engagement and interests. For more information on how we will use your
data to ensure we send you relevant content please visit our PRN Consumer Newsletter
Privacy Notice. You can withdraw your consent at any time in the footer of every email
you'll receive.
PRN Top Stories Newsletters
Enter Your Email
Select Country